Market Access Manager

Company: Cpl Life Sciences
Apply for the Market Access Manager
Location: Uxbridge
Job Description:

Overview

Title: Senior HTA & Market Access Project Manager (Oncology – NICE Submissions) – Contract

Location: Remote

Contract: 12 months initially (extensions likely)

Start Date: ASAP

We are supporting a global biopharmaceutical company in hiring an experienced Market Access / HTA specialist to lead upcoming NICE submission projects in oncology. This is a high-impact role where you’ll take ownership of end-to-end project delivery, from dossier development through to engagement with global and local stakeholders.

Key Priorities

  1. NICE Submission – Oncology
    • Lead and coordinate a vendor agency developing the submission dossier.
    • Provide technical input and ensure quality and compliance throughout.
    • Collaborate closely with Global HEOR and Market Access teams.
    • Develop and track project plans with key milestones.
  2. Market Entry Assessment – Oncology – Lung Cancer
    • Analyse clinical and health economic data to define UK market entry opportunities and pricing scenarios.
    • Present findings to UK & Ireland Market Access, Commercial, and Medical leaders.
    • If positive, lead NICE submission planning (submission anticipated Q4 2026).

Skills & Experience Required

  • Proven technical HTA / NICE submission experience (end-to-end delivery).
  • Strong project management skills with the ability to manage agencies and cross-functional teams.
  • Confident communicator, able to present complex detail and clear summaries.
  • Oncology experience highly desirable.
  • UK market access experience essential.

Why Join?

This is an opportunity to directly shape the UK launch and reimbursement strategy for innovative oncology therapies, working in a role that blends strategic oversight with technical delivery.

Seniority level

  • Mid-Senior level

Employment type

  • Full-time

Job function

  • Marketing

Industries

  • Pharmaceutical Manufacturing and Biotechnology Research

#J-18808-Ljbffr…

Posted: April 5th, 2026